These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 3002662
1. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Sys SU, Goenen MJ, Chalant CH, Brutsaert DL. Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662 [Abstract] [Full Text] [Related]
3. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA, Johnson DC. Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [Abstract] [Full Text] [Related]
4. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O, Sodowick B, Vulliemoz Y, Danilo P, Rosen M. Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [Abstract] [Full Text] [Related]
5. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M, Yanagisawa T, Taira N, Blinks JR. Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [Abstract] [Full Text] [Related]
6. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS, Eardley D, Watkins R, Prioli N. Biochem Pharmacol; 1986 Apr 01; 35(7):1113-21. PubMed ID: 2421728 [Abstract] [Full Text] [Related]
7. Effects of amrinone and milrinone on calcium influx into the myocardium. Sutko JL, Kenyon JL, Reeves JP. Circulation; 1986 Mar 01; 73(3 Pt 2):III52-8. PubMed ID: 3002664 [Abstract] [Full Text] [Related]
10. In vitro characterization of the effects of MCI-154, a novel cardiotonic agent, on cardiac tissues. Narimatsu A, Kitada Y, Satoh N, Morita M, Muroyama A, Kobayashi M, Ohizumi Y. Jpn J Pharmacol; 1989 Mar 01; 49(3):397-405. PubMed ID: 2545964 [Abstract] [Full Text] [Related]
11. Effect of milrinone on ethanol and halothane induced cardiodepression. Neira S, Penna M. Acta Physiol Pharmacol Latinoam; 1988 Mar 01; 38(2):193-211. PubMed ID: 2847492 [Abstract] [Full Text] [Related]
12. Phosphodiesterase-inhibiting properties of newer inotropic agents. Scholz H, Meyer W. Circulation; 1986 Mar 01; 73(3 Pt 2):III99-108. PubMed ID: 2417748 [Abstract] [Full Text] [Related]
16. Structure-activity relationships of milrinone analogues determined in vitro in a rabbit heart membrane Ca(2+)-ATPase model. Cody V, Wojtczak A, Davis FB, Davis PJ, Blas SD. J Med Chem; 1995 May 26; 38(11):1990-7. PubMed ID: 7783130 [Abstract] [Full Text] [Related]
19. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle. Satoh H, Endoh M. Jpn J Pharmacol; 1990 Feb 26; 52(2):215-24. PubMed ID: 2156096 [Abstract] [Full Text] [Related]
20. The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret. Gwathmey JK, Morgan JP. Br J Pharmacol; 1985 May 26; 85(1):97-108. PubMed ID: 2992656 [Abstract] [Full Text] [Related] Page: [Next] [New Search]